Role of GFAP in CNS injuries

被引:149
|
作者
Brenner, Michael [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Ctr Glial Biol Med, Dept Neurobiol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Ctr Glial Biol Med, Civitan Int Res Ctr, Birmingham, AL 35294 USA
关键词
GFAP; Astrocyte; CNS injury; Reactive gliosis; lschemia; Neurotrauma; FIBRILLARY ACIDIC PROTEIN; INTERMEDIATE-FILAMENT GFAP; SPINAL-CORD-INJURY; MICE DEFICIENT; ASTROCYTIC PROCESSES; NEURONAL SURVIVAL; HYPOTONIC STRESS; MULLER CELLS; WHITE-MATTER; VIMENTIN;
D O I
10.1016/j.neulet.2014.01.055
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The role of GFAP in CNS injury is reviewed as revealed by studies using GFAP null mice. In order to provide background information for these studies, the effects of absence of GFAP in the uninjured astrocyte are also described. Activities attributable to GFAP include suppressing neuronal proliferation and neurite extension in the mature brain, forming a physical barrier to isolate damaged tissue, regulating blood flow following ischemia, contributing to the blood-brain barrier, supporting myelination, and providing mechanical strength. However, findings for many of these roles have been variable among laboratories, pointing to the presence of unappreciated complexity in GFAP function. One complexity may be regional differences in GFAP activities; others are yet to be discovered. (c) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:7 / 13
页数:7
相关论文
共 50 条
  • [21] New GFAP splice isoform (GFAPμ) differentially expressed in glioma translates into 21 kDa N-terminal GFAP protein
    van Bodegraven, Emma J.
    Sluijs, Jacqueline A.
    Tan, A. Katherine
    Robe, Pierre A. J. T.
    Hol, Elly M.
    FASEB JOURNAL, 2021, 35 (03)
  • [22] Transplanting Microglia for Treating CNS Injuries and Neurological Diseases and Disorders, and Prospects for Generating Exogenic Microglia
    Var, Susanna R.
    Strell, Phoebe
    Johnson, Sether T.
    Roman, Alex
    Vasilakos, Zoey
    Low, Walter C.
    CELL TRANSPLANTATION, 2023, 32
  • [23] Regulation of GFAP Expression
    Brenner, Michael
    Messing, Albee
    ASN NEURO, 2021, 13
  • [24] Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis
    Katsipis, Georgios
    Tzekaki, Elena E.
    Tsolaki, Magda
    Pantazaki, Anastasia A.
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 361
  • [25] GFAP in health and disease
    Middeldorp, J.
    Hol, E. M.
    PROGRESS IN NEUROBIOLOGY, 2011, 93 (03) : 421 - 443
  • [26] The GFAP proteoform puzzle: How to advance GFAP as a fluid biomarker in neurological diseases
    Gogishvili, Dea
    Honey, Madison I. J.
    Verberk, Inge M. W.
    Vermunt, Lisa
    Hol, Elly M.
    Teunissen, Charlotte E.
    Abeln, Sanne
    JOURNAL OF NEUROCHEMISTRY, 2025, 169 (01)
  • [27] Targeting mTOR as a novel therapeutic strategy for traumatic CNS injuries
    Don, Aruni S. Arachchige
    Tsang, Chi Kwan
    Kazdoba, Tatiana M.
    D'Arcangelo, Gabriella
    Young, Wise
    Zheng, X. F. Steven
    DRUG DISCOVERY TODAY, 2012, 17 (15-16) : 861 - 868
  • [28] Splice site, frameshift, and chimeric GFAP mutations in Alexander disease
    Flint, Daniel
    Li, Rong
    Webster, Lital S.
    Naidu, Sakkubai
    Kolodny, Edwin
    Percy, Alan
    van der Knaap, Marjo
    Powers, James M.
    Mantovani, John F.
    Ekstein, Josef
    Goldman, James E.
    Messing, Albee
    Brenner, Michael
    HUMAN MUTATION, 2012, 33 (07) : 1141 - 1148
  • [29] Building a pathway to recovery: Targeting ECM remodeling in CNS injuries
    Butt, Ayub Mohammed
    Rupareliya, Vimal
    Hariharan, A.
    Kumar, Hemant
    BRAIN RESEARCH, 2023, 1819
  • [30] Neural stem cells as therapeutic agents for CNS injuries and disorders
    Okano, H
    MOLECULAR MECHANISMS AND EPOCHAL THERAPEUTICS OF ISCHEMIC STROKE AND DEMENTIA, 2003, 1252 : 493 - 498